Phase II Multicenter Trial of Bevacizumab Plus Fluorouracil and Leucovorin in Patients with Advanced Refractory Colorectal Cancer: An NCI Treatment Referral Center Trial TRC-0301
Phase 1 Safety and Immunogenicity Evaluation of a Multiclade HIV-1 Candidate Vaccine Delivered by a Replication-Defective Recombinant Adenovirus Vector